Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Dysrhythmias I: Introduction01:15

Dysrhythmias I: Introduction

Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bronchial Injury - Yet Another Collateral Damage of Cryoablation.

Journal of atrial fibrillation·2019
Same author

Cryoablation for atrioventricular nodal reentry tachycardia: Role of "mapping" and "pseudo-mapping".

Indian pacing and electrophysiology journal·2017
Same author

A meta-analysis of antibacterial envelope use in prevention of cardiovascular implantable electronic device infection.

Therapeutic advances in infectious disease·2017
Same author

J Wave Syndrome: Clinical Diagnosis, Risk Stratification and Treatment.

Journal of atrial fibrillation·2016
Same author

Pacing to prevent atrial fibrillation.

Current opinion in cardiology·2016
Same author

A Stunning Left Atrial Appendage Thrombus.

Cardiology·2016

Related Experiment Video

Updated: Jun 2, 2026

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
09:17

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation

Published on: July 29, 2011

Atrial fibrillation: current concepts.

Surendra K Chutani1, Naser Imran, Yousuf Kanjwal

  • 1Department of Cardiovascular Medicine, University of Toledo Medical Center, 3000, Arlington Avenue, Toledo, OH 43615, USA.

International Journal of Health Sciences
|April 9, 2011
PubMed
Summary
This summary is machine-generated.

Atrial fibrillation (AF), a common heart rhythm disorder, often requires individualized treatment due to medication limitations and bleeding risks. Ablation techniques are gaining interest for managing persistent or recurrent AF.

Keywords:
Atrial fibrillationPharmacologyRadiofrequency ablation

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Related Experiment Videos

Last Updated: Jun 2, 2026

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
09:17

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation

Published on: July 29, 2011

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, with incidence increasing significantly with age.
  • AF is linked to major morbidities, including stroke and heart failure, and tends to persist or recur after diagnosis.
  • Current pharmacotherapies for rate or rhythm control often experience secondary failure, necessitating alternative treatments.

Purpose of the Study:

  • To review the clinical aspects of atrial fibrillation, including its types, causes, and mechanisms.
  • To discuss the symptoms, complications, and individualized treatment approaches for AF.
  • To highlight the growing interest in ablation techniques for AF management.

Main Methods:

  • Review of clinical literature on atrial fibrillation.
  • Discussion of various treatment modalities, including pharmacotherapy and ablation.
  • Analysis of AF management strategies in different clinical scenarios.

Main Results:

  • Pharmacotherapy for AF has limitations and risks, including secondary failure and bleeding with anticoagulation.
  • Ablation techniques, particularly with innovative mapping, are emerging as a key treatment modality.
  • Individualized patient management is crucial for optimizing AF treatment outcomes.

Conclusions:

  • Atrial fibrillation management requires careful consideration of patient-specific factors due to treatment complexities.
  • Ablation techniques represent a promising therapeutic avenue for patients with persistent or recurrent AF.
  • Further research into innovative mapping and ablation strategies is warranted to improve AF treatment efficacy.